OA10033A - Solution hypertonique de cisplatine - Google Patents

Solution hypertonique de cisplatine Download PDF

Info

Publication number
OA10033A
OA10033A OA59680A OA59680A OA10033A OA 10033 A OA10033 A OA 10033A OA 59680 A OA59680 A OA 59680A OA 59680 A OA59680 A OA 59680A OA 10033 A OA10033 A OA 10033A
Authority
OA
OAPI
Prior art keywords
solution
cisplatin
sodium chloride
chloride
solutions
Prior art date
Application number
OA59680A
Other languages
English (en)
French (fr)
Inventor
Murray A Kaplan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of OA10033A publication Critical patent/OA10033A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA59680A 1988-11-14 1989-11-13 Solution hypertonique de cisplatine OA10033A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27033088A 1988-11-14 1988-11-14

Publications (1)

Publication Number Publication Date
OA10033A true OA10033A (en) 1996-10-14

Family

ID=23030884

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59680A OA10033A (en) 1988-11-14 1989-11-13 Solution hypertonique de cisplatine

Country Status (14)

Country Link
EP (1) EP0369714A1 (xx)
JP (1) JPH0321252A (xx)
AU (1) AU613810B2 (xx)
DD (1) DD292135A5 (xx)
DK (1) DK567689A (xx)
FI (1) FI895340A0 (xx)
HU (1) HU208074B (xx)
IL (1) IL92292A0 (xx)
NO (1) NO894505L (xx)
NZ (1) NZ231363A (xx)
OA (1) OA10033A (xx)
PT (1) PT92300A (xx)
YU (1) YU216689A (xx)
ZA (1) ZA898652B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1165455B (it) * 1983-07-06 1987-04-22 Consiglio Nazionale Ricerche Composizioni polimeriche a base di policaprolattame
JP2006342058A (ja) * 2003-06-20 2006-12-21 Otsuka Pharmaceut Factory Inc プラスチック製容器入りシスプラチン製剤
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
CA1162479A (en) * 1980-03-31 1984-02-21 Murray A. Kaplan Pharmaceutical formulations containing cisplatin
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
JPH072645B2 (ja) * 1986-06-12 1995-01-18 日本化薬株式会社 新規白金錯体製剤

Also Published As

Publication number Publication date
PT92300A (pt) 1990-05-31
EP0369714A1 (en) 1990-05-23
AU613810B2 (en) 1991-08-08
JPH0321252A (ja) 1991-01-30
AU4468389A (en) 1990-05-17
FI895340A0 (fi) 1989-11-09
NO894505L (no) 1990-05-15
DD292135A5 (de) 1991-07-25
NO894505D0 (no) 1989-11-13
DK567689D0 (da) 1989-11-13
IL92292A0 (en) 1990-07-26
NZ231363A (en) 1992-03-26
ZA898652B (en) 1990-07-25
DK567689A (da) 1990-05-15
HU895890D0 (en) 1990-02-28
YU216689A (en) 1991-06-30
HUT52373A (en) 1990-07-28
HU208074B (en) 1993-08-30

Similar Documents

Publication Publication Date Title
KR860001503B1 (ko) 이버멕틴의 수용화 방법
OA10678A (fr) Nouvelles formulations liquides stables à base de paracétamol et leur mode de préparation
WO2010055260A1 (fr) Nouvelle composition à base d'acide gamma-hydroxybutyrique
FR2571966A1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
BE1004168A3 (fr) Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv.
EP1108424A1 (fr) Comprimé matriciel permettant la libération prolongée de trimétazidine après administration par voie orale
EP1014948B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
JPWO2008090732A1 (ja) 医薬組成物
EP1102594B1 (fr) Utilisation de chlorure de sodium pour reduire la toxicite gastro-intestinale des derives de la camptothecine
EP3373953B1 (fr) Composition a action rapide d'insuline comprenant un citrate substitue
OA10033A (en) Solution hypertonique de cisplatine
BE1004051A4 (fr) Solution injectable et procede pour la preparer.
FR2509174A1 (fr) Composition anti-acide a base de n-acetyl-p-aminophenol
RU2019110218A (ru) Новые композиции на основе фуразидина и способы их изготовления
WO1998022107A1 (fr) Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
EP0542979B1 (fr) Composition therapeutique pour liberation prolongee de magnesium
WO1996033743A1 (fr) Compositions pulverulentes et solubles dans l'eau et leurs applications
FR2584604A1 (fr) Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
KR20120082061A (ko) 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물
JP3430965B2 (ja) 安定化された脂肪乳剤含有溶液
CA2472124A1 (fr) Composes amphiphiles a usage pharmaceutique ou cosmetique
TW202304426A (zh) 用於注射之包含１－（５－（２，４－二氟苯基）－１－（（３－氟苯基）磺醯基）－４－甲氧基－１ｈ－吡咯－３－基）－ｎ－甲基甲胺的新調配物
KR20210101193A (ko) 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제
FR2598082A1 (fr) Agent prophylactique et therapeutique de traitement de desordres hepatiques
JP2007191417A (ja) 医薬用の組成物